Abstract Highlighting Titan Medical’s SPORT Surgical System Presented at the American Association of Gynecologic Laparoscop...
November 15 2018 - 04:05PM
Business Wire
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD)
(Nasdaq: TMDI), a medical device company focused on the design,
development and commercialization of a robotic surgical system for
application in single-port minimally invasive surgery (“MIS”),
announces an abstract titled “Reverse Objective Structured
Assessment of Technical Skills (Reverse-OSATS) as a means of
measuring the capability of the Titan Medical SPORT Surgical System
on core surgical principles” was presented yesterday at the
American Association of Gynecologic Laparoscopists (AAGL) 2018
Global Congress. The abstract was presented by Chetna Arora, M.D.,
who also authored the abstract along with Arnold P. Advincula, M.D.
(both from Columbia University Medical Center) and William B.
Burke, M.D. (Stony Brook Cancer Center). The abstract is available
for viewing here.
The 47th AAGL Global Congress Annual Meeting was held in Las
Vegas from November 11-15.
David McNally, Titan’s President and CEO, said, “The abstract
presented at the AAGL concluded that the SPORT advanced prototype
system was able to successfully perform all the necessary surgical
tasks including grasping, cutting, dissection, suturing and
electrocautery during the study. This further validates the broader
design direction and offers unique insights into the fine-tuning of
the SPORT system for single-incision surgery. With our continued
emphasis on publications throughout 2018, we now have a total of
nine accepted and presented peer-reviewed abstracts based on the
extensive preclinical work accomplished earlier this year. The
presentation of this abstract at the AAGL meeting broadens
awareness for the SPORT system among our potential customers.”
The complete SPORT Preclinical Publications List is available
for viewing here.
Dr. Advincula said, “The Objective Structured Assessment of
Technical Skills is a well-accepted methodology for measuring the
skills of the surgeons. A novel use of this assessment tool allowed
us to reverse the focus to score the prototype functions. The core
surgical principals of Respect for Tissue (RFT), Time and Motion
(TM) and Instrument Handling (IH) were graded for a variety of
necessary surgical tasks. It was exciting to see that even in its
advanced prototype stage, the SPORT system demonstrated successful
performance in each of those necessary surgical tasks. This
exercise also allowed us to provide constructive product feedback
for fine-tuning of the technology for GYN surgeons interested in
performing single-incision robotic surgery.”
About AAGL
AAGL is one of the largest medical specialty societies focused
on gynecologic surgery and includes more than 7,500 physicians and
health care providers committed to advancing minimally invasive
gynecologic surgery (MIGS). AAGL’s Annual Global Congress is the
premiere scientific event that provides the world’s finest
gynecologic surgeons with the latest education and best practices
in MIGS. The theme of AAGL’s 47th Global Congress is “Honoring Our
Legacy as we Unite to Elevate Gynecologic Surgery” and will focus
on clinically relevant topics as well as recent developments,
instrumentation and surgical techniques presented by expert
faculty. AAGL’s Global Congress embodies their global commitment to
women’s healthcare by providing continuing medical education to
physicians and professionals to further promote the well-documented
high standards of minimally invasive gynecologic surgery.
About Titan Medical
Titan Medical Inc. is focused on research and development
through to the planned commercialization of computer-assisted
robotic surgical technologies for application in minimally invasive
surgery. The Company is developing the SPORT Surgical System, a
single-port robotic surgical system. The SPORT Surgical System is
comprised of a surgeon-controlled patient cart that includes a 3D
high-definition vision system and multi-articulating instruments
for performing MIS procedures, and a surgeon workstation that
provides an advanced ergonomic interface to the patient cart and a
3D endoscopic view inside the patient’s body. Titan intends to
initially pursue focused surgical indications for the SPORT
Surgical System, which may include one or more of gynecologic,
urologic, colorectal or general abdominal procedures.
For more information, please visit the Company’s website at
www.titanmedicalinc.com.
Forward-Looking Statements
This news release contains “forward-looking statements” within
the meaning of applicable Canadian and U.S. securities laws. Such
statements reflect the current expectations of management of the
Company’s future growth, results of operations, performance and
business prospects and opportunities. Wherever possible, words such
as “may”, “would”, “could”, “will”, “anticipate”, “believe”,
“plan”, “expect”, “intend”, “estimate”, “potential for” and similar
expressions have been used to identify these forward-looking
statements. These statements reflect management’s current beliefs
with respect to future events and are based on information
currently available to management. Forward-looking statements
involve significant risks, uncertainties and assumptions. Many
factors could cause the Company’s actual results, performance or
achievements to be materially different from any future results,
performance or achievements that may be expressed or implied by
such forward-looking statements, including, without limitation,
those listed in the “Risk Factors” section of the Company’s Annual
Information Form dated March 31, 2018 (which may be viewed at
www.sedar.com). Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
statements prove incorrect, actual results, performance, or
achievements may vary materially from those expressed or implied by
the forward-looking statements contained in this news release.
These factors should be considered carefully, and prospective
investors should not place undue reliance on the forward-looking
statements. Although the forward-looking statements contained in
the news release are based upon what management currently believes
to be reasonable assumptions, the Company cannot assure prospective
investors that actual results, performance or achievements will be
consistent with these forward-looking statements. Except as
required by law, the Company expressly disclaims any intention or
obligation to update or revise any forward-looking statements
whether as a result of new information, future events or
otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181115006019/en/
LHA Investor RelationsKim Sutton Golodetz(212)
838-3777kgolodetz@lhai.comorBruce Voss(310)
691-7100bvoss@lhai.com
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Feb 2024 to Mar 2024
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Mar 2023 to Mar 2024